Transthyretin Amyloid Cardiomyopathy Treatment Market Size & Share Analysis - Industry Research Report - Growth Trends

Transthyretin Amyloid Cardiomyopathy Treatment Market size was valued at US$ 1.69 Bn in 2022 and is projected to reach US$ 11.23 Bn by 2030, recording a CAGR of 31.10% during the forecast period.

2022年，转甲状腺蛋白淀粉样变性心肌病治疗市场规模已达16.9亿美元，预计到2030年将增长至112.3亿美元，在预测期内实现31.10%的复合年增长率。